CVAS-an interesting california-based biotech company here Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CVAS-an interesting california-based biotech company here

CVAS 0.000400

0.0%

Oct 7 9:32 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (114)	3/5/2003 11:59:04 AM
From: keokalani'nui	Read Replies (2) of 126

Lampert 100% right IMO. Corvas CEO should not make the decision for cvas shareholders to transform their investment from a primarily cash and blood clot company into a cancer vaccine company. What, he thinks he runs a mutual fund? The distinction between dndn and cvas is simply too great. If cvas CEO feels provenge, etc., opportunity is so great he needs to prepare PhD quality white paper on what he knows, certify it, seal it, and make it subject to review 2 years from now. By what insight does he now believe cancer vaccine is way to shareholder reward? Also (I am being facetious)), if he truly believes his strategy, why not use cvas cash to buy dndn stock (cheaper and more liquid)? Would be far better to liquidate assets and simply hibernate while new trial completes.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next